Metabolism and energy
Competitive drug displacement
Release of a bound drug when other substances compete for its binding sites
Hypotheses on this target 1
Inhibition1
Activation
Function preservation
Supplementation
Feedback restoration
Direct measurement
Inhibition1
Competition for tissue binding sites may release retained drug and worsen skin irritation
Where this hypothesis actsPreviously treated skin during therapy resumption after a treatment break
What is proposedPrevent competitive release of residual bound drug when therapy resumes
With whatNot stated in the record
HowEliminate the bound drug residue or the displacing formulation component; the procedure for doing so is not stated
Possible resultPossible stabilization of SPV_12 and resumption of therapy without increasing irritation
2026-09-25